financetom
Business
financetom
/
Business
/
Monster Beverage to Post Solid Q3 Results With Sales Growth Across All Markets, RBC Says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Monster Beverage to Post Solid Q3 Results With Sales Growth Across All Markets, RBC Says
Nov 5, 2025 8:50 AM

11:35 AM EST, 11/05/2025 (MT Newswires) -- Monster Beverage ( MNST ) is expected to post solid Q3 results, with sales growth across domestic and international markets, RBC Capital Markets said in a note Wednesday.

Sales in tracked US channels rose about 10.2% year over year in the September quarter, while energy drink category growth hit 16.4%, RBC said.

International demand remained strong, with double-digit category growth in all major regions despite earlier supply disruptions, according to the note.

RBC said it expects Monster to benefit from easier comparisons as it laps last year's hurricane-related and Europe, the Middle East and Africa supply chain issues.

The company raised prices to bottlers on Nov. 1, increasing 16-oz SKUs by roughly 5% and 12-oz by nearly 10%, the investment firm said.

Monster's October sales are projected to land in the low double-digit range, though last year's pull-forward impact creates some noise, RBC added.

RBC maintained its outperform rating for Monster with a $75 price target.

Price: 67.38, Change: +0.51, Percent Change: +0.76

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
CSP Shares Fall After Company Affirms Trading on Post-Split Basis March 21
CSP Shares Fall After Company Affirms Trading on Post-Split Basis March 21
Mar 8, 2024
02:17 PM EST, 03/08/2024 (MT Newswires) -- CSP (CSPI) shares fell 6.8% in recent Friday trading after the company affirmed its stock is expected to trade on a post-split basis at the market open on March 21. The shares under the company's 2-for-1 stock split, announced on Feb. 21, will be distributed from the transfer agent on March 20, according...
BMO Reviews AutoCanada's Q4 -- Trims Target by $1, to $23
BMO Reviews AutoCanada's Q4 -- Trims Target by $1, to $23
Mar 8, 2024
02:20 PM EST, 03/08/2024 (MT Newswires) -- AutoCanada's ( AOCIF ) Q4/23 headline EPS miss was due to unusual items in opex and higher-than-forecast underlying opex. The other parts of ACQ's Canadian business performed largely in line with BMO's expectations. The stock is trading at 6x BMO's revised 2025E EBITDA vs. historical range of 6-8x. Analyst Tamy Chen wonders if...
FDA approves Novo Nordisk's Wegovy for use in reducing heart attack risks
FDA approves Novo Nordisk's Wegovy for use in reducing heart attack risks
Mar 8, 2024
(Reuters) - The U.S. FDA has approved Novo Nordisk's Wegovy for use in lowering the risk of stroke and heart attack in overweight or obese adults who are not diabetic, the Danish drugmaker said on Friday. Novo's widely used diabetes drug Ozempic and weight-loss drug Wegovy, both chemically known as semaglutide, belong to a class of drugs called GLP-1 agonists....
Genesco Shares Decline Following Q4 Earnings Report
Genesco Shares Decline Following Q4 Earnings Report
Mar 8, 2024
02:18 PM EST, 03/08/2024 (MT Newswires) -- Genesco ( GCO ) shares were down more than 11% in recent Friday trading following the company's fiscal Q4 earnings report. The company reported fiscal Q4 adjusted earnings of $2.59 per share, down from $3.06 a year ago. Two analysts polled by Capital IQ expected $2.62. Net sales for the quarter ended Feb....
Copyright 2023-2026 - www.financetom.com All Rights Reserved